A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...
Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for ...
Congratulations to Michael McCrary (shown left in photo), Entrepreneur-in-Residence at the School of Management, and his ...
UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...
Viridian Therapeutics, Inc. , a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced the ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
Abstract: Artificial Intelligence Generated Content (AIGC) refers to AI-driven content generation techniques based on Generative Adversarial Networks and large pre-trained models. It leverages ...
In this exclusive interview, Panda Biotech’s President Dixie Carter outlines how U.S.-grown, cottonized hemp is moving from ...
In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...
Nanomedicine Innovations Transforming Oncology Drug Delivery And Bioavailability - Financial News Media. NetworkNewsWire Editorial Coverage New York, NY – October 29, 2025 – The global cancer-therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback